Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study and Treatment of Intraocular Retinoblastoma
NCT01783535Phase 2Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jun 2013
- Primary completion
- Mar 2023
- Modality
- DNA Intercalators/Alkylators, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, topotecan liposome in retinoblastoma (Rb), sponsored by St. Jude Children's Research Hospital. Started Jun 2013; status: active, not recruiting.
02
Drugs
carboplatintopotecan liposome
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT01783535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01783535.